IBIO - iBio, Inc.

NYSE American - Nasdaq Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 517.73M
Enterprise Value 329.68M
Trailing P/E N/A
Forward P/E 1N/A
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)13.49
Price/Book (mrq)2.56
Enterprise Value/Revenue 322.59
Enterprise Value/EBITDA 6-2.13

Trading Information

Stock Price History

Beta (3Y Monthly) -0.24
52-Week Change 31.45%
S&P500 52-Week Change 32.16%
52 Week High 31.4000
52 Week Low 30.5000
50-Day Moving Average 30.6965
200-Day Moving Average 30.8006

Share Statistics

Avg Vol (3 month) 331.38k
Avg Vol (10 day) 321.35k
Shares Outstanding 519.7M
Float 10.96M
% Held by Insiders 145.24%
% Held by Institutions 18.01%
Shares Short (Jul 31, 2019) 491.33k
Short Ratio (Jul 31, 2019) 42.39
Short % of Float (Jul 31, 2019) 40.95%
Short % of Shares Outstanding (Jul 31, 2019) 40.46%
Shares Short (prior month Jun 28, 2019) 4173.12k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 210/1
Last Split Date 3Jun 11, 2018

Financial Highlights

Fiscal Year

Fiscal Year Ends Jun 30, 2018
Most Recent Quarter (mrq)Mar 31, 2019


Profit Margin 0.00%
Operating Margin (ttm)-1,193.38%

Management Effectiveness

Return on Assets (ttm)-29.38%
Return on Equity (ttm)-316.83%

Income Statement

Revenue (ttm)1.31M
Revenue Per Share (ttm)0.08
Quarterly Revenue Growth (yoy)575.60%
Gross Profit (ttm)444k
EBITDA -13.94M
Net Income Avi to Common (ttm)-17.77M
Diluted EPS (ttm)-1.0520
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)9.04M
Total Cash Per Share (mrq)0.46
Total Debt (mrq)24.93M
Total Debt/Equity (mrq)361.27
Current Ratio (mrq)2.37
Book Value Per Share (mrq)0.35

Cash Flow Statement

Operating Cash Flow (ttm)-12.96M
Levered Free Cash Flow (ttm)-7.85M